News release: Gout drug colchicine doesn’t lessen COVID-19 severity or stave off risk of death – BMJ Original Study: Efficacy and safety of colchicine in COVID-19: a meta-analysis of randomised controlled trials – RMD Open Related: RECOVERY Trial: In patients admitted to hospital with COVID-19, Colchicine did not reduce 28-day mortality, duration of hospital stay, […]

The post M-A: Colchicine doesn’t lessen COVID-19 severity or stave off risk of death. appeared first on Links Medicus.